《功能性脂类》PPT课件.ppt
《《功能性脂类》PPT课件.ppt》由会员分享,可在线阅读,更多相关《《功能性脂类》PPT课件.ppt(119页珍藏版)》请在三一办公上搜索。
1、PUFA,Arachidonic Acid(AA),Source,AnimalPlantHuman 40%50%of brain and nerve PUFA plasm 400mg/L milk from mother 0.4%Microorganism Hyphochytrimycete Hytridiomycetes Oomycetes Mortierella,AA is the precursors of Eicosanoids:Prostaglandins and leukotrienes are locally acting,hormone-like lipids derived
2、from dietarily essential unsaturated fatty acids that are important drug targets Actions of prostaglandins include:inflammatory,pain/fever,blood clotting(via control of platelet-endothelial cell interactions),intestinal,renal,uterine effectsActions of leukotrienes include:mainly hypersensitivity and
3、 allergic reactions,Synthesis of Eicosanoids,R=H or CH3,In cell membrane,Hydrolysis of sn-2 ester bondby phospholipase A2(PLA2)or C,Arachidonate,Liberation of arachidonic acid and its metabolism to prostaglandins/thromboxanes or to leukotrienes,Synthesis of Prostaglandin,Cyclicendoperoxide,Hydropero
4、xide,Prostaglandinendoperoxidesynthetase,(COX-1),COX-2,Hydroperoxidase,Prostaglandin endoperoxide synthetase(also called cyclooxygenase)possesses both cyclooxygenase and hydroperoxidase activityTwo forms of cyclooxygenase:COX-1-constitutively expressed COX-2-inducible,PGH2,PGG2,PGH2central intermedi
5、ate(Head of pathway),PGF2labor induction(Fetus),Conversion of PGH2 to prostaglandins and thromboxane of the“2-series”,TXB2 inactive,Non-Enzymatic,Leukotriene Biosynthesis,Arachidonic acid,5-Hydroperoxyeicosa-6,8,11,14-tetraenoic acid(5-HPETE),5-Lipoxygenase,Leukotriene A4(LTA4),5-Lipoxygenase,Glutat
6、hioneLTC4 synthase,Leukotriene C4(LTC4),Leukotriene E4(LTE4),-Glu-Gly,LTAHydrolase,Leukotriene B4(LTB4),Leukotrienes areimportant mediatorsof inflammation,Cysteinyl leukotrienes,Leukotriene Biosynthesis(Contd),Arachidonic acid,12-Lipoxygenase,12-Hydroperoxyeicosa-5,8,10,14-tetraenoic acid(12-HPETE),
7、12-Hydroxyeicosa-5,8,10,14-tetraenoic acid(12-HETE),Leukotriene Receptor,Accolate,Anti-inflammatory glucocorticoids inhibit phospholipase A2 and,therefore,prevent both prostaglandin and leukotriene formationNonsteroidal anti-inflammatory drugs(NSAIDs)inhibit cyclooxygenase(COX),and thus prevent only
8、 prostaglandin/thromboxane synthesisZyflo inhibits lipoxygenase to preclude only leukotriene synthesis;Accolate is a selective leukotriene receptor antagonist(blocker),Cyclooxygenase(COX)Inhibitors,Nonsteroidal antiinflammatory drugs:,Acetylsalicylic acid(aspirin),Ser-530,Irreversible inhibition of
9、COX by acetylationof the active site,Actions of Aspirin:Antiinflammatory(COX-2 inhibition)GI injury(COX-1 inhibition),COX-2 Selective Inhibitors,Rofecoxib(Vioxx),Celecoxib(Celebrex),Glucocorticoids block COX-2 expression,Leukotriene Biosynthesis Inhibition,Zileuton(Zyflo)An inhibitor of 5-lipoxygena
10、seUsed in the treatment of asthma,Function of Prostaglandins,TXA2 platelets aggregation vasoconstrictionPGI2 endothelial cells platelet disaggregation vasodilation gastric mucosa decreased stomach acidPGE2 many cells waking pain inflammation fever renal arteriolar dilation,Function of Prostaglandins
11、,PGD2 mast cells,fat cells sleep precursor to PGJ2PGF2 labor inducingPGJ2 fat cells from PGD2 induces fat cell differentiation,Biological activities of leukotrienes,LTB4-potent chemoattractent-mediator of hyperalgesia-growth factor for keratinocytesLTC4-constricts lung smooth muscle-promotes capilla
12、ry leakage 1000 X histamineLTD4-constricts smooth muscle-lung airway hyperactivity-vasoconstrictionLTE4-1000 x less potent than LTD4(except in asthmatics),Function of AA,Second signal Improve cAMP,cGMPImmunity HETEs,HPETEs,LT inhibit immune cell LTB4,LTD4,LTE4 inhibit immunityCardiovascular Disease,
13、Liver and GallbladderInflammationNerveCell Division,Application,Nannie,Pregnant,Baby FAO/WHO baby recipe milk powder AA 60mg/kg DHA 40mg/kg,Application,Improve remember and eyesightAdjust blood TG and SugarPrevent CVDAnti-tumorCometicOther,Animal experiment results,AA的产业化技术路线,工业化生产,菌体,提油,菌体胶囊,干菌体,油胶
14、囊,功能保健品,纯化油,食品添加剂,高级饲料,前列腺素,科 研,新 药,-FA,Zhang Dequan,-3 PUFA,18:2 Linoleic acid(LA)18:3-Linolenic acid(GLA)20:3 Dihomo-linolenic acid20:4 Arachidonic acid(AA)22:4 Adrenic acid,18:3-Linolenic acid(LNA)20:5 Eicosapentaenoic acid(EPA)22:5 Docosapentaenoic acid(DPA)22:6 Docosahexaenoic acid(DHA),-6 PUFA
15、,KINDS,-6 and-3 synthesize,-6 LA GLA AA-6 eicosanoids,-3 LNA EPA DHA-3 eicosanoids,Eicosanoids synthesis,AA,PGH2,The eicosanoids and their biosynthetic origins.A)Synthesis from-6 precursors,LA(6),PGI2,PGE2,PGD2,PGF2,TXA2,TXB2,LTs,A.,The eicosanoids and their biosynthetic origins.B)Synthesis from-3 p
16、recursors,B.,-Linolenic Acid(3 essential fatty acid)for membrane integrity in phospholipids,Diet-3 fatty acids,Eicosapentaenoic Acid EPA(3)for membrane integrity in phospholipids,plant sources,Docosahexaenoic Acid DHA(3)in breast milk;required forinfant brain development,-FA also leads to production
17、 of PGI3 and TXA3PGI3 production is favored,and it also has much greater intrinsic activity(than its TXA3 counter-hormone)to favor vasodilation and platelet disaggregation with a reduced risk of thrombosis(blood clotting).This explains why-3 dietary fatty acids prevent vascular disease and heart att
18、acks,Control of platelet aggregation.Suppression of platelet aggregation by drug or dietary intervention,-6 promote TXA2 synthesizing-3 promote TXA3 synthesizing,FUNCTIONAnticancer,CVD,-6 promote PGE2 synthesizing-3 inhibit PGE2 synthesizing-3 inhibit platelet aggregation and blood to clot by promot
19、ing formation TXA3,PGI3modify dyslipidemia EPA/DHA inhibit VLDL and apoB,by lower triacylglycerols and Cholesterol,increase in HDL2-C,improve arterial function,inhibit monocytes migratinon into plaque,and cytkine,PDGF and its mRNA production,relax blood vessels and reduce BP by stimulate endothelial
20、 production of NOanti arrhythmias by altering cell membrane fatty acids composition and electrophysiological function,reduce vulnerability to ventricular fibrillation,and less risk of cardiac arrest&sudden death anti-inflammation by reducing production of TXB2,PGE2,-6Decreased Chol&LDL CSmall reduct
21、ion HDLSmall reduction TGsLower serum cholesterolIncreased thromboxane A2 Increased prostacylin 12 Control of inflammationPlatelet aggregationVasoconstriction/dilationMembrane structure-fluidity,receptors,enzymes and channels,-3 Decreased Chol&TGLittle effect on LDLDecreased thromboxane A2Increased
22、prostacylin 12 Antithrombotic effect Reduce platelet aggregationPreventing cardiac arrestDecreasing risk of breast and colon cancerBoth omega 3 and 6 FA improve blood pressure,Omega 3 FA has a greater effect than omega 6 FA,LNA,Structure,-Linolenic ALA 18:3 cis9,12,15-Linolenic GLA 18:3 cis 6,9,12,A
23、LA GLA EPA Dihomo-GLA DHA AA,ALA,Perilla oil 45%50%oil,ALA 60%Linseed oil 35%oil,ALA 50%,GLA,Evening Primrose 23%30%oil,GLA 8%10%,CONJUGATED LINOLEIC ACID CLA,STRUCTURE,trans 10,cis 12 CLAcis 9,trans 11 CLAlinoleic acid,HISTORY,1951.Nichols synthesize CLA.1966,.Kepler discover that 9c,11t-CLA is the
24、 mediators of hydrogenation of linoleic in ruminant.1978,Michael Pariza dicover CLA can anticancer.1985,Pariza,CLA inhibit mouse skin cancer.1991,Ha et al,CLA inhibit BP induced tumor.1994,Ip,CLA inhibit mouse galactophore cancer.1990s,the evidence of CLA anti-tumor.1997,Pariza,CLA decrease fat mass
25、,increase LBM.1999,Japan,built CLA plant,CLA capsule of decreasing fat come into market in USA.2002,China,CLA“Tenth five Plan”.2003,CLA product will come into market,Body Composition,Increased lean body mass(LBM)and decreased fat mass(FM)提高肉毒碱棕榈酰转移酶(一种脂肪-氧化的限速酶)提高荷尔蒙敏感酶(负责脂肪水解释放至血液中的酶)inhibit 脂蛋白脂肪酶
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 功能性脂类 功能 性脂类 PPT 课件
链接地址:https://www.31ppt.com/p-5472456.html